Professor Robert Brown’s Epigenetics Team examines how gene expression can be regulated without involving gene mutations.
Professor Robert Brown is researching epigenetics and the mechanisms of cancer drug resistance, particularly for ovarian cancer. He is Principle Investigator of the Cancer Research UK research programme, Pharmacodynamics and Drug Resistance, and is Co-Principle Investigator in the Ovarian Cancer Action Research Centre.